A Clinical Study of Autologous Peripheral Blood Stem Cell Mobilization for PEG-G-CSF
Status:
Not yet recruiting
Trial end date:
2025-04-30
Target enrollment:
Participant gender:
Summary
Have a comparison between pegylated recombinant human granulocyte colony stimulating factor
(PEG-rhG-CSF) and granulocyte-colony stimulating factor (G-CSF) for difference in efficacy of
hematopoietic reconstruction after autologous peripheral blood stem cell mobilization (
PBSCM) and autologous peripheral blood stem cell transplantation (APBSCT).
Primary purpose:
1. Count of collected CD34+ cells and mononuclear cells.
2. Proportion of patients with successful mobilization (CD34+ > 2×106 /kg)
Secondary purpose:
1. Proportion of qualified patients in a single collection.
2. Neutrophil and platelet reconstruction time